ClearLight Biotechnologies and Researchers at the Indiana University’s Melvin and Bren Simon Cancer CenterAnnounce the publication of “Three-dimensional Imaging and Quantitative Analysis in CLARITY Processed Breast Cancer Tissues, “in Scientific Reports-Nature.

Posted on Apr 11, 2019

Posted: April 11, 2019
source: PRNewswire

SUNNYVALE, CA April 11, 2019 (PR NEWSWIRE)

ClearLight Biotechnologies, LLC announced today the publication of their first peer-reviewed manuscript in collaboration with authors, Sunil Badve, M.D. and Yesim Gokmen-Polar, Ph.D. Current technologies utilized for preclinical and clinical drug development in cancer are largely dependent upon the 2-dimensional (2D) analysis of thin Formalin-Fixed Paraffin-Embedded (FFPE) tissue sections (5-10 µm). However, the importance of understanding cellular phenotypic information combined with three-dimensional (3D) spatial analysis of tissues is paramount, especially with respect to accurately predicting outcomes for immunotherapy drugs. This manuscript describes the use of the novel method, CLARITY, to process and immunolabel breast cancer core needle biopsies, followed by a 3D quantitative analysis of a nuclear proliferation marker, Ki67. While there was overall concordance against the gold standard technique, the CLARITY processed tissues (3D) revealed variation in the intra-tumoral Ki67 expression that was not evident in individual FFPE sections (2D). The team also demonstrated compatibility of this method with archived FFPE samples, establishing early feasibility for use in processing retrospective clinical samples with associated clinical outcome data. This work provides the foundation for future large-scale clinical sample processing and the non-destructive 3D analysis of tumor tissue by this unique method. “The currently commercially available techniques provide limited spatial data by the multiplexed analyses of a thin (5-micron) section of tissue,” said Dr. Sunil Badve, M.D., Joshua Edwards Professor of Pathology and Laboratory Medicine and Director of the Translational Genomics Core. “The CLARITY technology holds promise to revolutionize spatial analysis by enabling 3D analysis of thick (up to 1000-micron) tumor to achieve more biologically relevant information regarding tumor heterogeneity and key spatial relationships in the tumor microenvironment.”

“By partnering with the team at the Indiana University’s Melvin and Bren Simon Cancer Center, we have been able to work with world renowned experts in the clinical and translational field, while greatly advancing our platform development program,” commented Laurie Goodman, Ph.D. Chief Executive Officer at ClearLight Biotechnologies. “We look forward to future collaborative work to establish the clinical utility of the technology.”

Direct link to manuscript: https://rdcu.be/buB5j

About ClearLight

Founded by Karl Deisseroth M.D., Ph.D., ClearLight is developing an automated instrumentation platform based on the CLARITY lipid-clearing technique developed by Dr. Deisseroth and colleagues at Stanford University. This technique enables the transformation of tissue into a nanoporous, hydrogel-hybridized form that is crosslinked to a three-dimensional network of hydrophilic polymers. The process produces a fully assembled, intact tissue, which is permeable to macromolecules and optically transparent, thus allowing for robust three-dimensional imaging of subcellular components (DNA, RNA and protein) and analysis of heterogeneous cellular interactions within the microenvironment of a tissue. This technology, paired with proprietary 3D image analysis software, will enable more accurate analysis and assessment of normal and diseased tissue.

Please visit and follow us at:

Website: www.clearlightbiotechnologies.com
LinkedIn: https://www.linkedin.com/in/clearlight-biotechnologies-llc-ab0970172/
Twitter: https://twitter.com/ClearlightBio
YouTube: https://www.youtube.com/channel/UCXKptXdwz68uZEo8Z-CiRsw

Contact: Laurie Goodman, Ph.D., CEO
contact@clearlightbiotech.com
(800) 251-8905

Terms and Conditions

Please read these terms and conditions (“terms”, “terms and conditions”) carefully before using [website] website (the “service”) operated by [name] (“us”, ‘we”, “our”).

Conditions of Use

We will provide their services to you, which are subject to the conditions stated below in this document. Every time you visit this website, use its services or make a purchase, you accept the following conditions. This is why we urge you to read them carefully.

Privacy Policy

Before you continue using our website we advise you to read our privacy policy [link to privacy policy] regarding our user data collection. It will help you better understand our practices.

Copyright

Content published on this website (digital downloads, images, texts, graphics, logos) is the property of [name] and/or its content creators and protected by international copyright laws. The entire compilation of the content found on this website is the exclusive property of [name], with copyright authorship for this compilation by [name].

Communications

The entire communication with us is electronic. Every time you send us an email or visit our website, you are going to be communicating with us. You hereby consent to receive communications from us. If you subscribe to the news on our website, you are going to receive regular emails from us. We will continue to communicate with you by posting news and notices on our website and by sending you emails. You also agree that all notices, disclosures, agreements and other communications we provide to you electronically meet the legal requirements that such communications be in writing.

Applicable Law

By visiting this website, you agree that the laws of the [your location], without regard to principles of conflict laws, will govern these terms and conditions, or any dispute of any sort that might come between [name] and you, or its business partners and associates.

Disputes

Any dispute related in any way to your visit to this website or to products you purchase from us shall be arbitrated by state or federal court [your location] and you consent to exclusive jurisdiction and venue of such courts.

Comments, Reviews, and Emails

Visitors may post content as long as it is not obscene, illegal, defamatory, threatening, infringing of intellectual property rights, invasive of privacy or injurious in any other way to third parties. Content has to be free of software viruses, political campaign, and commercial solicitation.

We reserve all rights (but not the obligation) to remove and/or edit such content. When you post your content, you grant [name] non-exclusive, royalty-free and irrevocable right to use, reproduce, publish, modify such content throughout the world in any media.

License and Site Access

We grant you a limited license to access and make personal use of this website. You are not allowed to download or modify it. This may be done only with written consent from us.

User Account

If you are an owner of an account on this website, you are solely responsible for maintaining the confidentiality of your private user details (username and password). You are responsible for all activities that occur under your account or password.

We reserve all rights to terminate accounts, edit or remove content and cancel orders in their sole discretion.

Tissue Requirements

Stay informed

Stay up to date with ClearLight’s advances in 3D Tissue Spatial Analysis and CLARITY. We’ll never share your email address or information.